VANCOUVER, Wash. and NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced.
28.08.2023 - VANCOUVER, Wash. and NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) - Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences. H.C. .
Shares of Arcus Biosciences, Inc. (RCUS) are surging over 30% on Wednesday morning. The company announced its participation in multiple upcoming investor conferences.
23.08.2023 - Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in the following .